Literature DB >> 10923725

Late steroid therapy in primary acute lung injury.

T Varpula1, V Pettilä, E Rintala, O Takkunen, V Valtonen.   

Abstract

OBJECTIVE: To investigate the effect of steroid treatment in the late phase of primary acute lung injury (ALI) with special emphasis on pneumococcal pneumonia.
DESIGN: Retrospective study.
SETTING: Multidisciplinary intensive care unit (ICU) in a university hospital. PATIENTS: Of 31 patients with primary ALI requiring mechanical ventilation for more than 10 days, 16 were treated with methylprednisolone and 15 served as controls. MEASUREMENTS AND
RESULTS: Steroid and control groups were comparable regarding demographic data, APACHE II score, Multiple Organ Dysfunction Score (MODS), and PaO2/FiO2-ratio on admission to ICU. The mean start of steroid therapy was 9.7 days after establishment of respiratory failure, and values for control patients were registered on day 10. The PaO2/FiO2 ratio improved significantly within 3 days after the start of steroid therapy, and MODS and C-reactive protein decreased concurrently. No differences in mortality, in length of ICU stay, or in length of mechanical ventilation were detectable. In a subgroup analysis, for patients with Streptococcus pneumoniae pneumonia, beneficial change in physiological variables was evident.
CONCLUSIONS: In patients with primary ALI, steroid therapy, started 10 days after the start of mechanical ventilation, improves gas exchange and is associated with a decrease in multiorgan dysfunction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923725     DOI: 10.1007/s001340051199

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  8 in total

1.  Late steroid therapy in primary acute lung injury.

Authors:  U Corbanese
Journal:  Intensive Care Med       Date:  2001-02       Impact factor: 17.440

Review 2.  [Corticosteroid administration for acute respiratory distress syndrome : therapeutic option?].

Authors:  P Möhnle; J Briegel
Journal:  Anaesthesist       Date:  2012-04       Impact factor: 1.041

Review 3.  The acute respiratory distress syndrome.

Authors:  Ariel M Modrykamien; Pooja Gupta
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-04

Review 4.  Steroids for acute respiratory distress syndrome?

Authors:  Catherine L Hough
Journal:  Clin Chest Med       Date:  2014-09-24       Impact factor: 2.878

5.  Prehospital use of inhaled steroids and incidence of acute lung injury among patients at risk.

Authors:  Emir Festic; Enrique Ortiz-Diaz; Augustine Lee; Guangxi Li; Daryl J Kor; Adesanya Adebola; Ozan Akca; Jason Hoth; Joseph E Levitt; Rickey Carter; Ognjen Gajic
Journal:  J Crit Care       Date:  2013-09-24       Impact factor: 3.425

6.  Efficacy and safety of low-dose corticosteroids for acute respiratory distress syndrome: A systematic review and meta-analysis.

Authors:  Yu-Qing Cui; Xian-Fei Ding; Huo-Yan Liang; Dong Wang; Xiao-Juan Zhang; Li-Feng Li; Quan-Cheng Kan; Le-Xin Wang; Tong-Wen Sun
Journal:  World J Emerg Med       Date:  2021

Review 7.  Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis.

Authors:  Sheng-Yuan Ruan; Hsien-Ho Lin; Chun-Ta Huang; Ping-Hung Kuo; Huey-Dong Wu; Chong-Jen Yu
Journal:  Crit Care       Date:  2014-04-07       Impact factor: 9.097

Review 8.  Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us.

Authors:  Andreas Schwingshackl; Gianfranco Umberto Meduri
Journal:  Front Pediatr       Date:  2016-06-14       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.